Femasys 

$0.52
0
-$0.01-2.09% Today

Statistics

Day High
0.55
Day Low
0.52
52W High
-
52W Low
-
Volume
661
Avg. Volume
-
Mkt Cap
30.35M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26MarExpected
Q3 2025
Next
-0.12
-0.11
-0.1
-0.09
Expected EPS
-0.085
Actual EPS
N/A

Financials

-1,155.13%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.26MRevenue
-37.63MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FEMY.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in women's health products and diagnostics, directly competing with Femasys in the gynecological and reproductive health market.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies, Inc. provides various healthcare products, including women's health and fertility solutions, making it a direct competitor in the reproductive health sector.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers medical technologies, services, and solutions, including those for gynecological surgery and health, competing in the broader women's health market.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including women's health.
ICU Medical
ICUI
Mkt Cap3.03B
ICU Medical, Inc. manufactures medical devices used in vascular therapy, oncology, and critical care applications, indirectly competing in the healthcare solutions sector.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including medical devices and pharmaceuticals, competing in the broader healthcare market.
Dexcom
DXCM
Mkt Cap22.71B
DexCom, Inc. specializes in glucose monitoring systems but competes in the larger medical device market, indirectly affecting companies like Femasys.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products, competing in the medical device industry.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of healthcare products, including medical devices and diagnostics, competing in the global healthcare market.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of healthcare products, indirectly competing across multiple sectors, including women's health.

About

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Show more...
CEO
Ms. Kathy Lee-Sepsick M.B.A.
Employees
69
Country
US
ISIN
US31447E1055

Listings

0 Comments

Share your thoughts

FAQ

What is Femasys stock price today?
The current price of FEMY.BOATS is $0.52 USD — it has decreased by -2.09% in the past 24 hours. Watch Femasys stock price performance more closely on the chart.
What is Femasys stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Femasys stocks are traded under the ticker FEMY.BOATS.
What is Femasys market cap?
Today Femasys has the market capitalization of 30.35M
When is the next Femasys earnings date?
Femasys is going to release the next earnings report on March 26, 2026.
What were Femasys earnings last quarter?
FEMY.BOATS earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.12 USD resulting in a +13.04% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Femasys revenue for the last year?
Femasys revenue for the last year amounts to 3.26M USD.
What is Femasys net income for the last year?
FEMY.BOATS net income for the last year is -37.63M USD.
How many employees does Femasys have?
As of February 03, 2026, the company has 69 employees.
In which sector is Femasys located?
Femasys operates in the Health Care sector.
When did Femasys complete a stock split?
Femasys has not had any recent stock splits.
Where is Femasys headquartered?
Femasys is headquartered in Suwanee, US.